The latest trading session saw Novavax (NVAX) ending at $12.66, denoting a -1.33% adjustment from its last day's close. The stock trailed the S&P 500, which registered a daily loss of 0.41%. At the same time, the Dow lost 0.12%, and the tech-heavy Nasdaq lost 0.71%. The the stock of vaccine maker has fallen by 15.87% in the past month, lagging the Medical sector's gain of 1.74% and the S&P 500's gain of 3.53%. Analysts and investors alike will be keeping a close eye on the performance of Novavax in its upco ...